Albumin is the main protein of plasma, binding different molecules and regulating the colloidal osmotic pressure of blood.
Although the mechanism for Ischemia-Modified Albumin production is unknown, stroke might modify the N-terminus of albumin altering its binding capacity.
Baseline Ischemia-Modified Albumin (IMA) blood levels may be a biomarker for early identification of acute stroke, but not to differentiate Ischemic from hemorrhagic stroke patients. On the other hand, serum albumin is decreased in those patients who die following a stroke. No significant association has been found between vWf levels and aetiological subtypes of ischemic stroke.
No ignificant difference at plasma level between stroke subtypes.